Terminated NA INTERVENTIONAL 1-arm NCT00372138

Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms

Prevention of Endoleaks Using Autologous Platelet Gel During Endovascular Procedures on Unruptured Abdominal Aortic Aneurysms: Pilot Study

Sponsor: Medtronic

Conditions Abdominal Aortic Aneurysms

Interventions PRP + autologous thrombin

Updated 5 times since 2017 Last updated: Mar 1, 2012 Started: Sep 30, 2006 Primary completion: Oct 31, 2007 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Medtronic

See all terminations from Medtronic

Other Abdominal Aortic Aneurysms trials with similar outcome

Browse all Abdominal Aortic Aneurysms trials

This NA trial investigates Abdominal Aortic Aneurysms and is currently terminated or withdrawn. Medtronic leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
Rennes University Hospital

Data source: Rennes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rennes, France